Skip to main content

INEX Innovate at MEDICA 2022 Dusseldorf to showcase the OvaCis® Rapid Test Kit – the world’s first intraoperative rapid test to effectively discriminate benign from malignant ovarian cysts.

By November 8, 2022November 14th, 2022No Comments

Leave a Reply

About the Technology

A simple sample collection using the common HPV swab is taken and the DNA is extracted. The extracted DNA undergoes bisulfite conversion before an accurate method of screening through real-time PCR analyses. The bisulfite conversion functions by converting unmethylated Cytosine nucleotides to Uracil, which is then converted to Thymine by PCR. Conversely, the methylation mark protects the methylated Cytosine nucleotides from being converted to Uracil.